Protalix BioTherapeutics Inc (PLX)
1.10
-0.15
(-12.00%)
USD |
NYAM |
May 10, 16:00
1.11
+0.01
(+0.91%)
After-Hours: 20:00
Protalix BioTherapeutics Market Cap: 80.36M for May 10, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 10, 2024 | 80.36M |
| May 09, 2024 | 91.32M |
| May 08, 2024 | 83.28M |
| May 07, 2024 | 83.28M |
| May 06, 2024 | 81.09M |
| May 03, 2024 | 83.28M |
| May 02, 2024 | 84.74M |
| May 01, 2024 | 88.39M |
| April 30, 2024 | 83.28M |
| April 29, 2024 | 87.66M |
| April 26, 2024 | 84.01M |
| April 25, 2024 | 86.20M |
| April 24, 2024 | 88.39M |
| April 23, 2024 | 87.66M |
| April 22, 2024 | 86.20M |
| April 19, 2024 | 84.01M |
| April 18, 2024 | 82.55M |
| April 17, 2024 | 84.01M |
| April 16, 2024 | 83.28M |
| April 15, 2024 | 83.28M |
| April 12, 2024 | 86.20M |
| April 11, 2024 | 89.12M |
| April 10, 2024 | 92.05M |
| April 09, 2024 | 96.43M |
| April 08, 2024 | 94.97M |
| Date | Value |
|---|---|
| April 05, 2024 | 85.47M |
| April 04, 2024 | 88.39M |
| April 03, 2024 | 90.58M |
| April 02, 2024 | 90.58M |
| April 01, 2024 | 91.32M |
| March 28, 2024 | 92.05M |
| March 27, 2024 | 91.32M |
| March 26, 2024 | 89.12M |
| March 25, 2024 | 89.12M |
| March 22, 2024 | 92.78M |
| March 21, 2024 | 96.43M |
| March 20, 2024 | 97.89M |
| March 19, 2024 | 94.97M |
| March 18, 2024 | 92.78M |
| March 15, 2024 | 97.16M |
| March 14, 2024 | 100.08M |
| March 13, 2024 | 111.04M |
| March 12, 2024 | 104.46M |
| March 11, 2024 | 105.20M |
| March 08, 2024 | 108.85M |
| March 07, 2024 | 106.66M |
| March 06, 2024 | 108.12M |
| March 05, 2024 | 111.04M |
| March 04, 2024 | 114.69M |
| March 01, 2024 | 118.34M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
26.06M
Minimum
Oct 14 2019
282.28M
Maximum
Apr 23 2021
91.28M
Average
83.91M
Median
Jan 31 2023
Market Cap Benchmarks
| Agenus Inc | 220.28M |
| InfuSystems Holdings Inc | 155.23M |
| AIM ImmunoTech Inc | 19.96M |
| Perspective Therapeutics Inc | 1.027B |
| Armata Pharmaceuticals Inc | 102.29M |
Market Cap Related Metrics
| PE Ratio | 55.50 |
| PS Ratio | 1.318 |
| Price to Book Value | 2.416 |
| Price | 1.10 |
| Earnings Yield | 1.80% |
| Operating PE Ratio | 8.252 |
| Normalized PE Ratio | 55.50 |